Glucose Health (ID) Aktie - GLUC

Glucose Health Inc (ID) (GLUC) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

0,49

( - )

Gebot

0,395

Fragen

0,54

Volumen

0,00 Tagesbereich 0,00

0,02 52-Wochen-Bereich 0,6735

Marktkapitalisierung

13,112M

Handelsende

0,49

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

US$ 18.058

Ausgegebene Aktien

26.759.271

Dividendenrendite (LTM)

Kurs-Gewinn-Verhältnis

-18,01

Gewinn pro Aktie (EPS)

-0,03

Erlöse (LTM)

1,11M

Nettogewinn (LTM)

-355,97k

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. Th... Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas. Mehr anzeigen

Sektor

Consumer Staples

Branche

Consumer Products - Foods

Website

www.glucosehealthinc.com

Hauptsitz

Bentonville, United States

Gegründet

2026

Glucose Health Inc (ID) is listed in the Consumer Staples sector of the OTC Markets with ticker GLUC. The last closing price for Glucose Health (ID) was US$0,49. Over the last year, Glucose Health (ID) shares have traded in a share price range of US$ 0,02 to US$ 0,6735.

Glucose Health (ID) currently has 26.759.271 shares in issue. The market capitalisation of Glucose Health (ID) is US$13,11 million. Glucose Health (ID) has a price to earnings ratio (PE ratio) of -18.01.

Glucose Health, Inc. (GLUC) Reports Surge in GlucoDown Sales Among two of the Largest Retailers in the National Drug Store Channel

Bentonville, ARKANSAS, June 18, 2026 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTCID:GLUC), the maker of...

Glucose Health, Inc. (GLUC) Appoints Gerry David as Chairman of Strategic Advisory Board of Directors

Bentonville, ARKANSAS, June 04, 2026 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (GLUC) (the “Company”), a...

Glucose Health Expands Retail Distribution to 2,500+ Stores, Launches National Advertising Campaign

BENTONVILLE, Ark., March 04, 2026 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a consumer-health...

Form D - Notice of Exempt Offering of Securities

Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand

BENTONVILLE, Ark., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a consumer-health...

Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy

BENTONVILLE, Ark., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a consumer-health...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.0432	-8.10202550638	0.5332	0.54	0.43915	10083	0.49007896	CS
4	0.18	58.064516129	0.31	0.55	0.3	20888	0.44708691	CS
12	0.0201	4.27750585231	0.4699	0.55	0.3	18648	0.39051375	CS
26	0.3151	180.160091481	0.1749	0.6735	0.166	25435	0.36955739	CS
52	0.4	444.444444444	0.09	0.6735	0.02	33661	0.19680646	CS
156	0.14	40	0.35	0.9001	0.02	20330	0.24410945	CS
260	-2.96	-85.7971014493	3.45	3.64	0.02	17602	0.63358328	CS

GLUC - Frequently Asked Questions (FAQ)

What is the current Glucose Health Inc (ID) share price?

The current share price of Glucose Health Inc (ID) is US$ 0,49

How many Glucose Health Inc (ID) shares are in issue?

Glucose Health Inc (ID) has 26.759.271 shares in issue

What is the market cap of Glucose Health Inc (ID)?

The market capitalisation of Glucose Health Inc (ID) is USD 13,11M

What is the 1 year trading range for Glucose Health Inc (ID) share price?

Glucose Health Inc (ID) has traded in the range of US$ 0,02 to US$ 0,6735 during the past year

What is the PE ratio of Glucose Health Inc (ID)?

The price to earnings ratio of Glucose Health Inc (ID) is -18,01

What is the cash to sales ratio of Glucose Health Inc (ID)?

The cash to sales ratio of Glucose Health Inc (ID) is 11,17

What is the registered address of Glucose Health Inc (ID)?

The registered address for Glucose Health Inc (ID) is 609 SW 8th Street, Bentonville, Arkansas, 72712

What is the Glucose Health Inc (ID) website address?

The website address for Glucose Health Inc (ID) is www.glucosehealthinc.com

Which industry sector does Glucose Health Inc (ID) operate in?

Glucose Health Inc (ID) operates in the Consumer Products - Foods sector

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Glucose Health Inc (ID) (GLUC)

Glucose Health Inc (ID) (GLUC) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Glucose Health Inc (ID)

GLUC Neueste Nachrichten

Glucose Health, Inc. (GLUC) Reports Surge in GlucoDown Sales Among two of the Largest Retailers in the National Drug Store Channel

Glucose Health, Inc. (GLUC) Appoints Gerry David as Chairman of Strategic Advisory Board of Directors

Glucose Health Expands Retail Distribution to 2,500+ Stores, Launches National Advertising Campaign

Form D - Notice of Exempt Offering of Securities

Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand

Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy

Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth

Form D - Notice of Exempt Offering of Securities

Glucose Health, Inc. Appoints Strategic Investor Christopher J. Jemapete to Its Board of Directors

Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors

Glucose Health, Inc. (GLUC) Reports Surge in GlucoDown Sales Among two of the Largest Retailers in the National Drug Store Channel

Glucose Health, Inc. (GLUC) Appoints Gerry David as Chairman of Strategic Advisory Board of Directors

Glucose Health Expands Retail Distribution to 2,500+ Stores, Launches National Advertising Campaign

Form D - Notice of Exempt Offering of Securities

Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand

Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy

Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth

Form D - Notice of Exempt Offering of Securities

GLUC - Frequently Asked Questions (FAQ)

GLUC Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen